efavirenz/emtricitabine/tenofovir disoproxil fumarate
Sponsors
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
HIV InfectionsHIV-1 InfectionKaposi's Sarcoma
Phase 2
Phase 3
Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
CompletedNCT01352117
Start: 2011-11-18End: 2018-11-29Updated: 2019-11-14
Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants
CompletedNCT03048422
Start: 2018-01-19End: 2020-10-03Updated: 2022-11-21